http://www.tapanray.in A Tapan Ray Website Sun, 22 Mar 2026 10:59:18 +0000 en-US hourly 1 http://wordpress.org/?v=3.4.2 http://www.tapanray.in/us-biosimilar-overhaul-a-breakthrough-moment-or-a-strategic-test-for-indian-pharma/?utm_source=rss&utm_medium=rss&utm_campaign=us-biosimilar-overhaul-a-breakthrough-moment-or-a-strategic-test-for-indian-pharma http://www.tapanray.in/us-biosimilar-overhaul-a-breakthrough-moment-or-a-strategic-test-for-indian-pharma/#comments Sun, 09 Nov 2025 08:01:06 +0000 Tapan Ray http://www.tapanray.in/?p=10996 Continue reading →]]> http://www.tapanray.in/us-biosimilar-overhaul-a-breakthrough-moment-or-a-strategic-test-for-indian-pharma/feed/ 0 http://www.tapanray.in/shifting-pharma-supply-chain-strategy-from-global-to-local/?utm_source=rss&utm_medium=rss&utm_campaign=shifting-pharma-supply-chain-strategy-from-global-to-local http://www.tapanray.in/shifting-pharma-supply-chain-strategy-from-global-to-local/#comments Mon, 08 Jun 2020 00:00:14 +0000 Tapan Ray http://www.tapanray.in/?p=10120 Continue reading →]]> http://www.tapanray.in/shifting-pharma-supply-chain-strategy-from-global-to-local/feed/ 0 http://www.tapanray.in/protect-generic-drug-margin-moving-up-the-value-chain/?utm_source=rss&utm_medium=rss&utm_campaign=protect-generic-drug-margin-moving-up-the-value-chain http://www.tapanray.in/protect-generic-drug-margin-moving-up-the-value-chain/#comments Mon, 03 Dec 2018 00:00:03 +0000 Tapan Ray http://www.tapanray.in/?p=9276 Continue reading →]]> http://www.tapanray.in/protect-generic-drug-margin-moving-up-the-value-chain/feed/ 0 http://www.tapanray.in/a-toxin-delaying-success-of-biosimilar-drugs/?utm_source=rss&utm_medium=rss&utm_campaign=a-toxin-delaying-success-of-biosimilar-drugs http://www.tapanray.in/a-toxin-delaying-success-of-biosimilar-drugs/#comments Mon, 06 Aug 2018 00:00:46 +0000 Tapan Ray http://www.tapanray.in/?p=9086 Continue reading →]]> http://www.tapanray.in/a-toxin-delaying-success-of-biosimilar-drugs/feed/ 0 http://www.tapanray.in/rigged-payment-system-limits-biosimilar-access/?utm_source=rss&utm_medium=rss&utm_campaign=rigged-payment-system-limits-biosimilar-access http://www.tapanray.in/rigged-payment-system-limits-biosimilar-access/#comments Mon, 02 Apr 2018 00:00:05 +0000 Tapan Ray http://www.tapanray.in/?p=8908 Continue reading →]]> http://www.tapanray.in/rigged-payment-system-limits-biosimilar-access/feed/ 0 http://www.tapanray.in/indian-drug-control-worlds-weakest-pharma-trade-bodies-working-at-cross-purposes/?utm_source=rss&utm_medium=rss&utm_campaign=indian-drug-control-worlds-weakest-pharma-trade-bodies-working-at-cross-purposes http://www.tapanray.in/indian-drug-control-worlds-weakest-pharma-trade-bodies-working-at-cross-purposes/#comments Mon, 25 Apr 2016 00:00:25 +0000 Tapan Ray http://www.tapanray.in/?p=7612 Continue reading →]]> http://www.tapanray.in/indian-drug-control-worlds-weakest-pharma-trade-bodies-working-at-cross-purposes/feed/ 0 http://www.tapanray.in/the-curious-conundrum-of-new-drugs-approval-process/?utm_source=rss&utm_medium=rss&utm_campaign=the-curious-conundrum-of-new-drugs-approval-process http://www.tapanray.in/the-curious-conundrum-of-new-drugs-approval-process/#comments Mon, 18 Jan 2016 00:00:05 +0000 Tapan Ray http://www.tapanray.in/?p=7360 Continue reading →]]> http://www.tapanray.in/the-curious-conundrum-of-new-drugs-approval-process/feed/ 0 http://www.tapanray.in/is-drug-price-control-the-key-growth-barrier-for-indian-pharma-industry/?utm_source=rss&utm_medium=rss&utm_campaign=is-drug-price-control-the-key-growth-barrier-for-indian-pharma-industry http://www.tapanray.in/is-drug-price-control-the-key-growth-barrier-for-indian-pharma-industry/#comments Mon, 19 Oct 2015 00:00:14 +0000 Tapan Ray http://www.tapanray.in/?p=7183 Continue reading →]]> http://www.tapanray.in/is-drug-price-control-the-key-growth-barrier-for-indian-pharma-industry/feed/ 0 http://www.tapanray.in/nutraceuticals-an-emerging-opportunity-in-the-gray-area-between-pharma-and-nutrition/?utm_source=rss&utm_medium=rss&utm_campaign=nutraceuticals-an-emerging-opportunity-in-the-gray-area-between-pharma-and-nutrition http://www.tapanray.in/nutraceuticals-an-emerging-opportunity-in-the-gray-area-between-pharma-and-nutrition/#comments Mon, 17 Nov 2014 00:00:37 +0000 Tapan Ray http://www.tapanray.in/?p=6190 Continue reading →]]> http://www.tapanray.in/nutraceuticals-an-emerging-opportunity-in-the-gray-area-between-pharma-and-nutrition/feed/ 0 http://www.tapanray.in/pioglitazone-conundrum-should-the-drug-regulator-step-over-the-line/?utm_source=rss&utm_medium=rss&utm_campaign=pioglitazone-conundrum-should-the-drug-regulator-step-over-the-line http://www.tapanray.in/pioglitazone-conundrum-should-the-drug-regulator-step-over-the-line/#comments Mon, 08 Jul 2013 00:00:54 +0000 Tapan Ray http://www.tapanray.in/?p=2883 Continue reading →]]> http://www.tapanray.in/pioglitazone-conundrum-should-the-drug-regulator-step-over-the-line/feed/ 0